Back To Search Instructions
10 protocols meet the specified criteria
Disease Site: Ovary
Protocol No.TitleStatus
1200000138Biospecimen Repository for Individuals at High Risk for Breast, Ovarian, or Other Hereditary CancersOpen
1401187428A Phase 2, Open-Label Study of Rucaparib in Patients with Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (CO-338-017 / ARIEL 2)Open
1404299159Imaging of the ovary with a volume holographic imaging system: pilot studyOpen
1411572748A Novel Method of Screening for Ovarian Cancer using Gynecologic Fluids and Mucus (USA-MCI GON-1.04)Open
1502660379S1316: Prospective Comparative Effectiveness Trial for Malignant Bowel ObstructionOpen
1504771536Continued Recruitment of High-Risk and Low-Risk control subjects to assess biomarkers of ovarian cancer riskOpen
1505838152A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rucaparib as Switch Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube CancerOpen
1508036559A Multicentre Randomised Phase II Study of AZD1775 plus Chemotherapy versus Chemotherapy Alone in Patients with Platinum-Resistant TP53-Mutated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerOpen
1511209984Can Diet and Physical Activity Modulate Ovarian Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?Open (affiliates only)
1511224935A Randomized, Open-Label Study Comparing the Combination of YONDELIS(R) and DOXIL(R) / CAELYX(R) With DOXIL(R) / CAELYX(R) Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerOpen